Triamcinolone is an intermediate-acting synthetic glucocorticoid-9 "-Fluoro-16 "-hydroxyprednisolone. It is five times more potent than hydrocortisone. It was approved by FDA 1 and patented for the treatment of perennial and seasonal allergic rhinitis. Its mechanism of action includes multiple anti-inflammatory actions such as reduced fluid transudation, inhibition of anti-inflammatory cytokines and interference with fibroblast and endothelial cell function.
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Intraocular pharmacological considerations include its minimally water-soluble suspension formulation, hence prolonged action and lack of tissue toxicity noted in animal and human studies. 2 Recent developments have demonstrated the importance of triamcinolone in the management of ophthalmic conditions. Researchers and clinicians have shown its efficacy in the management of posterior segment diseases.
It is readily available and cheap in Nigeria, [3] [4] [5] [6] [7] [8] [9] [10] hence the need for ophthalmic practitioners to be aware of its use and how to administer the medication appropriately. Indications for intravitreal triamcinolone include primary treatment of macular oedema from diabetic retinopathy, retinal vein occlusion and posterior uveitis. It has also been found to be useful in cystoid macular oedema, idiopathic juxtafoveal telangiectasia and neovascular agerelated macular degeneration.
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METHOD OF INTRAVITREAL ADMINISTRATION
Pre-injection Patient Selection and Evaluation
The injection is contraindicated in patients with glaucoma, and better avoided in the presence of ocular surface infections such as blepharitis, conjunctivitis and stye. This will reduce the risk of endophthalmitis.
Anaesthesia: Topical anaesthesia is adequate, but for uncooperative patients, we give peribulbar anaesthesia in our centre.
Mydriasis:
The pupil is dilated for indirect ophthalmoscopy before, during and after injection.
The procedure is an aseptic procedure; we administer the injection in the operating theatre in our centre. Apply cotton bud to injection site to prevent reflux.
Anterior chamber paracentesis is performed if digital IOP is high or arterial pulsation noted on indirect ophthalmoscopy.
a. Use 25-27G needle, cotton bud to stabilize the eye b. Watch the lens in phakics c. It is avoided in aphakics as vitreous will come to AC Post-injection povidone iodine drops and indirect ophthalmoscopy are mandatory to check for arterial pulsation, a sign of optic nerve vascular compromise; if present, repeat paracentesis.
• Pad the eye overnight, patient is advised to assume a sitting position for the first 6 hrs to avoid triamcinolone crystals settling on fovea.
• The intraocular pressure should be checked within 24 hours; follow up is then scheduled for one week, one month, three months and six monthly thereafter.
• Topical ciprofloxacin four times daily is recommended in the first week of injection.
COMPLICATIONS OF INTRAVITREAL TRIAMCINOLONE
Complications associated with intravitreal triamcinolone have been documented. They are: 
